Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
---|
05/19/2004 | CN1150165C 1-arenesulfonyl-2-aryl-pyrolidine and piperidine derivativer for treatment of CNS disorders |
05/18/2004 | US6737533 Pigmented vitreous material |
05/18/2004 | US6737440 2,5-bis ((alkyl (or aryl) imino) aminophenyl) furans, thiophenes or pyrroles |
05/18/2004 | US6737429 Pyrrole derivatives |
05/18/2004 | US6737422 Voltage-dependent |
05/13/2004 | WO2004039799A1 Cyclopropyl-thienyl-carboxamide as fungicides |
05/13/2004 | WO2004039795A2 Amide compounds for the treatment of hyperlipidemia |
05/13/2004 | WO2004039784A1 Novel phenylethanolamine derivatives and the use of the same as beta-3-agonists |
05/13/2004 | WO2004039370A1 Sulfonamides, sulfamates and sulfamides as gamma-secretase inhibitors |
05/13/2004 | WO2004039318A2 Anti-infective biaryl compounds |
05/13/2004 | WO2004026305A9 Diaryl ethers as opioid receptor antagonist |
05/13/2004 | WO2004024065A3 Substituted bicyclic thiophene derivatives, compostions containing such compounds and methods of use |
05/13/2004 | US20040093165 Estrogen receptor ligands |
05/13/2004 | US20040092746 Fungicides |
05/13/2004 | US20040092687 Polymeric charge transport compositions and electronic devices made with such compositions |
05/13/2004 | US20040092628 Heat and oxidation resistance; photostability; for automobile coatings, candle wax |
05/13/2004 | US20040092604 Amino-tetralin derivatives as muscarinic receptor antagonists |
05/13/2004 | US20040092576 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
05/13/2004 | US20040092569 Analgesics, antiinflammatory agents, autoimmune diseases, bone disorders, central nervous system disorders |
05/13/2004 | US20040092564 1-Aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
05/13/2004 | US20040092556 Aids therapy |
05/13/2004 | US20040092554 4-piperidinyl alkyl amine derivatives as muscarinic receptor antagonists |
05/13/2004 | US20040092550 Anticholesterol agents; cardiovascular disorders |
05/13/2004 | US20040092535 Anticancer agents; antidiabetic agents; Alzheimer's disease; autoimmune disease |
05/13/2004 | US20040092526 Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands |
05/13/2004 | US20040092524 Novel aminophenyl piperazine or aminophenyl piperidine derivatives inhibiting prenyl transferase proteins and method for preparing same |
05/13/2004 | US20040092521 Antihistamines; central nervous system disorders |
05/13/2004 | US20040092515 Diaminoquinazoline esters for use as dihydrofolate reductase inhibitors |
05/13/2004 | US20040092507 Melanocortin receptor agonists |
05/13/2004 | US20040092505 Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone |
05/13/2004 | US20040092454 3-biphenyl-4-yl-3-(2-(4-(pyridin-2-ylamino)pentanoylamino)-pen tanoyl amino)propionic acid derivatives |
05/13/2004 | DE10251170A1 Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel New beta-agonists, to processes for their preparation and their use as medicaments |
05/13/2004 | CA2504213A1 New beta-agonists, processes for preparing them and their use as pharmaceutical compositions |
05/13/2004 | CA2503119A1 Anti-infective biaryl compounds |
05/12/2004 | EP1418176A1 Pyrazole derivates, their preparation and their use in drugs |
05/12/2004 | EP1417202A2 Aminopiperidine derivatives as modulators of chemokine receptor activity |
05/12/2004 | EP1417201A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
05/12/2004 | EP1417196A1 Dna-pk inhibitors |
05/12/2004 | EP1417190A1 Substituted piperazines as modulators of the melanocortin receptor |
05/12/2004 | EP1417181A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
05/12/2004 | EP1417177A2 Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents |
05/12/2004 | EP1416936A1 Thiopyrane-4-ones as dna protein kinase inhibitors |
05/12/2004 | EP1416933A1 Substituted piperidines as modulators of the melanocortin receptor |
05/12/2004 | EP1416928A2 N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents |
05/12/2004 | EP1250336B1 Piperidine derivatives and their use as serotonin receptor antagonists |
05/12/2004 | EP1140835B1 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives |
05/12/2004 | EP1066267B1 Substituted phenyl uracils |
05/12/2004 | EP1063235B1 Benzofurylpyrone derivatives |
05/12/2004 | EP1036065B1 Substituted imidazole derivatives having agonist-like activity at alpha 2b or 2b/2c adrenergic receptors |
05/12/2004 | EP0927192B1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production |
05/12/2004 | CN1496364A Substituted quinazoline derivatives and their use as inhibitors |
05/12/2004 | CN1496362A Non-imidazole compounds as histamine H3 antagonists |
05/12/2004 | CN1496348A 5-cyano-1H-indole derivatives as antagonists of interleukine-8 receptors |
05/12/2004 | CN1495186A Method for preparing enkephalinase and angiotensin-converting enzyme inhibitor intermediate and its intermediate |
05/12/2004 | CN1495180A Method for preparing 2-alkyl-3-aminothiophene derivative and 3-aminothiophene derivative |
05/12/2004 | CN1495177A C-10 position paclitaxane derivative and its medicine composition |
05/12/2004 | CN1495171A Indazol compound for inhibiting protein kinase and medicine composition and their application |
05/12/2004 | CN1495170A Substituted pyrazolyl benzsulfamide compound for curing inflammation |
05/12/2004 | CN1495160A I-substituted-1-aminomethyl-cycloalkane derivative (gabapentin analogs), its preparation and application for curing neuropathy |
05/12/2004 | CN1494906A Application of compound in preparation of medicine for preventing and curing multiple drug resistance |
05/12/2004 | CN1149212C Peperidine derivatives as reuptake inhibitors |
05/12/2004 | CN1149211C Benzoyl derivatives, method for producing them and their use as herbicids and plant growth regulators |
05/12/2004 | CN1149210C Thrombin inhibitors |
05/12/2004 | CN1149209C Triazole compounds with dopamine-D3-receptor affinity |
05/12/2004 | CN1149195C 5-HTIF agonists |
05/12/2004 | CN1149193C Substituted tricyclic compound |
05/12/2004 | CN1149191C Azetidine derivatives, Preparation and medicines containing them |
05/12/2004 | CN1149085C Inhibition of RAF kinase using substituted heterocyclic useas |
05/11/2004 | US6734302 Cis-imidazolines |
05/11/2004 | US6734191 Chemokine receptor binding heterocyclic compounds |
05/11/2004 | US6734184 Arylpiperazines and their use as metalloproteinase inhibiting agents (MMP) |
05/11/2004 | US6734176 Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation |
05/11/2004 | CA2184411C Process for preparing polymorphs b and c of 1-[2,4-dichloro-.beta.-[(7-chlorobenzo[b]thien-3-yl)methoxy]phenethyl]imidazole mononitrate |
05/11/2004 | CA2136999C Peripheral vasodilating agent containing piperidine derivative as active ingredient |
05/06/2004 | WO2004037820A1 Oxindole substituted piperazine derivatives |
05/06/2004 | WO2004037818A1 1-acyl-pyrrolidine derivatives for the treatment of viral infections |
05/06/2004 | WO2004037814A1 Indazolinone compositions useful as kinase inhibitors |
05/06/2004 | WO2004037805A1 Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
05/06/2004 | WO2004037789A2 Methylene urea derivatives as raf-kinase inhibitors |
05/06/2004 | WO2004037788A1 Bicyclic benzamide compounds as histamine h3 receptor ligand useful in the treatment of neurological diseases |
05/06/2004 | WO2004037787A1 1-phenylpyrrolidine-2-one-3-carboxamides |
05/06/2004 | WO2004037776A2 Novel compounds and their use as prar-modulators |
05/06/2004 | WO2004037775A1 Novel compounds useful in treating ppar mediated diseases |
05/06/2004 | WO2004037248A2 Modulation of peroxisome proliferator activated receptors activity |
05/06/2004 | WO2004037247A1 Oxindoles with anti-hiv activity |
05/06/2004 | WO2004018451A8 Pyridazinone-derivatives as pde4 inhibitors |
05/06/2004 | WO2004018449A8 Piperidine-derivatives as pde4 inhibitors |
05/06/2004 | WO2004013131A3 Pyridines and pyrimidines substituted by 4-trifluoromethylpyrazolyl |
05/06/2004 | WO2003106428A8 Arylsulphonamide derivatives and use thereof as b1 bradykinin receptor antagonists |
05/06/2004 | WO2003105779A3 Guanidine compounds as anesthetics and for treatment of nervous system disorders |
05/06/2004 | WO2003097604A9 Pyridine carboxamide derivatives and their use as pesticides |
05/06/2004 | WO2003082853A8 New compounds |
05/06/2004 | WO2003040096A3 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
05/06/2004 | US20040087798 Novel amide compounds |
05/06/2004 | US20040087796 Substituted carbazoles as inhibitors of spla2 |
05/06/2004 | US20040087788 Oxime-substituted pyridin-2-yl-substituted thiophenes, e.g., N-(1-(6-(1-benzothiophen-2-yl)-2-pyridinyl)ethylidene)-2,6 -diisopropylaniline; used to prepare olefin polymerization catalysts |
05/06/2004 | US20040087646 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
05/06/2004 | US20040087638 Antidiabetic agents; antilipemic agents; anticholesterol agents; cardiovascular disorders; side effect reduction |
05/06/2004 | US20040087637 Antiserotonine agents; central nervous system disorders |
05/06/2004 | US20040087627 Decarboxylase inhibitors; cardiovascular diosrders; antidiabetic agents; anticancer agents; dietetics |